NCT02164838 2018-01-29
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
Clinical Trials
1 trialsNETWORK × Refractory or Recurrent Solid Tumors, Excluding CNS Tumors × Other solid neoplasm × Clear all